ResearcherCentral South UniversityNo recent work listed

S Shang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0004-0844-6143; OpenAlex author ID A5006312102. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 2 papers

Papers 2

Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer. Co-author DOI 10.1002/cam4.2633 ↗
[Clinical significance of exosomal miR-1231 in pancreatic cancer]. Co-author DOI 10.3760/cma.j.issn.0253-3766.2019.01.008 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chaohui Zuo · 2 shared papers, 2019 · strength 0.18
- Paper Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer. DOI 10.1002/cam4.2633 ↗
- Paper [Clinical significance of exosomal miR-1231 in pancreatic cancer]. DOI 10.3760/cma.j.issn.0253-3766.2019.01.008 ↗
Yu Zhang · 1 shared paper, 2019 · strength 0.09
- Paper [Clinical significance of exosomal miR-1231 in pancreatic cancer]. DOI 10.3760/cma.j.issn.0253-3766.2019.01.008 ↗
S L Chen · 1 shared paper, 2019 · strength 0.09
- Paper [Clinical significance of exosomal miR-1231 in pancreatic cancer]. DOI 10.3760/cma.j.issn.0253-3766.2019.01.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.